))
Ep. 71 - Pazdur Unplugged: FDA Director Richard Pazdur on the Past, Future of Cancer Treatments
Manage episode 447887439 series 3571902
コンテンツは BioCentury によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャスト コンテンツは、BioCentury またはそのポッドキャスト プラットフォーム パートナーによって直接アップロードされ、提供されます。誰かがあなたの著作物をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal。
Richard Pazdur, director of FDA’s Oncology Center of Excellence, joined FDA in 1999. Looking back on his 25th anniversary, he draws a line between unpopular decisions at the start of his tenure and a surge in cancer drug development over the last 20 years. He believes this and other lessons from the regulation of oncology can be applied broadly across FDA. The BioCentury Show discussed these lessons, as well as Pazdur’s views about advisory committees, pragmatic trials, dose optimization and more.
This episode of The BioCentury Show was sponsored by Cytiva. To gain more insights into therapeutic advances and biopharma sustainability, read the report now available on cytiva.com.
View full story: https://www.biocentury.com/article/654032
#biotech #biopharma #pharma #lifescience #RandD #drugapproval #regulation
00:00 - Introduction
01:55 - Rejecting the ineffective
10:56 - Creating Consensus
16:43 - Fire From the Dragon’s Mouth
24:30 - Three Reasons for Trial Equity
29:28 - Dose Optimization
章
1. Ep. 71 - Pazdur Unplugged: FDA Director Richard Pazdur on the Past, Future of Cancer Treatments (00:00:00)
2. Rejecting the ineffective (00:01:55)
3. Creating Consensus (00:10:56)
4. Fire From the Dragon’s Mouth (00:16:43)
5. Three Reasons for Trial Equity (00:24:30)
6. Dose Optimization (00:29:28)
21 つのエピソード
シェア
